Equities

Sinovac Biotech Ltd

Sinovac Biotech Ltd

Actions
  • Price (EUR)5.50
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Feb 22 2019 16:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue4481,49319,375
OPERATING EXPENSES
Cost of revenue total1826841,072
Selling, general and admin. expenses, total469828594
Depreciation/amortization------
Unusual expense(income)795.210.98
Other operating expenses, total(22)(0.76)(0.73)
Total operating expense1,0511,9591,822
Operating income(603)(466)17,553
Other, net367302(90)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(153)2517,563
Provision for income taxes105(63)3,104
Net income after taxes(258)8814,459
Minority interest15826(5991)
Net income before extra. Items(100)1148,467
Total extraordinary items------
Net income(100)1148,467
Inc.avail. to common excl. extra. Items(106)1088,461
Inc.avail. to common incl. extra. Items(106)1088,461
EPS RECONCILIATION
Basic/primary weighted average shares10010099
Basic/primary eps excl. extra items(1.06)1.0885
Basic/primary eps incl. extra items(1.06)1.0885
Dilution adjustment------
Diluted weighted average shares100114114
Diluted eps excl. extra items(1.06)0.9474
Diluted eps incl. extra items(1.06)0.9474
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock--00
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.261.262.84
SUPPLEMENTAL INCOME
Depreciation, supplemental14015484
Total special items795.210.98
NORMALISED INCOME
Normalized income before taxes(74)3017,564
Effect of special items on income taxes281.820.17
Income tax excluding impact of special items133(61)3,104
Normalized income after tax(207)9214,460
Normalized income avail. to common(55)1118,462
Basic normalized EPS(0.55)1.1285
Diluted normalized EPS(0.55)0.9774
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.